ADMA Biologics
ADMA
ADMA
319 hedge funds and large institutions have $3.5B invested in ADMA Biologics in 2024 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 124 increasing their positions, 103 reducing their positions, and 57 closing their positions.
Holders
319
Holders Change
+14
Holders Change %
+4.59%
% of All Funds
4.25%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
75
Increased
124
Reduced
103
Closed
57
Calls
$43.8M
Puts
$15.7M
Net Calls
+$28.1M
Net Calls Change
-$2.79M
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$94.9M |
2 |
2
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$10.1M |
3 |
3
D.E. Shaw & Co
New York
|
$52.6M |
4 |
4
Bank of Montreal
Toronto,
Ontario, Canada
|
$456K |
5 |
AIC
5
AWM Investment Company
New York
|
$41.6M |